Neuroprotective Effect of Natural Compounds in Paclitaxel-Induced Chronic Inflammatory Pain

Area of Science:

• Pharmacology
• Neuroscience
• Natural Products Chemistry

Background:

• Paclitaxel (PTX) chemotherapy can cause debilitating neuroinflammatory pain.
• Natural compounds possess potential therapeutic properties for managing chemotherapy side effects.
• Berbamine, bergapten, and carveol are natural compounds with known anti-inflammatory activities.

Purpose of the Study:

• To investigate the efficacy of berbamine, bergapten, and carveol in mitigating paclitaxel-induced neuroinflammatory pain.
• To elucidate the molecular mechanisms underlying the neuroprotective effects of these natural compounds.

Main Methods:

• Neuropathic pain was induced in a preclinical model using paclitaxel.
• Behavioral analyses assessed pain sensitivity, body weight, and motor function.
• Molecular analyses included measuring oxidative stress markers (GSH, LPO), inflammatory mediators (iNOS, COX-2, TNF-α, NF-κB), and performing histological examinations (H&E, IHC).

Main Results:

• Berbamine, bergapten, and carveol treatment significantly reduced thermal hypersensitivity and improved motor function.
• These compounds normalized body weight changes and increased pain sensation thresholds.
• Treatment increased protective glutathione (GSH) and glutathione S-transferase (GST) levels, while decreasing inducible nitric oxide synthase (iNOS) and lipid peroxidase (LPO).
• Histological examinations and molecular analyses confirmed the reversal of paclitaxel-induced neuropathic changes and inhibition of inflammatory markers (COX-2, TNF-α, NF-κB).

Conclusions:

• Berbamine, bergapten, and carveol demonstrate significant neuroprotective effects against paclitaxel-induced neuroinflammatory pain.
• These natural compounds offer a promising therapeutic strategy for managing chemotherapy-induced neuropathic pain.
• The neuroprotective mechanisms involve the modulation of oxidative stress and inflammatory pathways.